Published on September 24, 2012 at 8:14 AM
Teleflex Incorporated (NYSE:TFX) today announced the ARROW FlexBlock
continuous peripheral nerve block catheter has received 510(k) clearance
from the U.S. Food and Drug Administration (FDA).
The ARROW FlexBlock continuous peripheral nerve block catheter is
intended for clinicians who use ultrasound-guidance when placing
continuous peripheral nerve block catheters. The echogenic,
coil-reinforced FlexBlock catheter body is constructed of polyurethane,
and the unique catheter design offers a combination of ultrasound
visibility, flexibility, and excellent kink resistance. The FlexBlock
catheter's tip design is intended to provide clinicians with a
predictable spread of anesthetic.
"Teleflex is pleased to be adding the ARROW FlexBlock catheter to our
market-leading line of ARROW® StimuCath®
continuous peripheral nerve block catheters," said Cary Vance,
President, Teleflex Anesthesia and Respiratory. "These products, in
addition to the StimuQuik® ECHO peripheral nerve block
needles, SureBlock® spinal trays, and the recently 510(k)
cleared FlexTip Plus® Multi-Port epidural catheters, give
Teleflex a clinically differentiated regional anesthesia product
portfolio, designed to meet the needs of anesthesiologists in the field
of regional anesthesia and acute pain management."
Source: Teleflex Incorporated